173 related articles for article (PubMed ID: 36473763)
1. Efficacy of Levosimendan in the Treatment of Patients With Severe Septic Cardiomyopathy.
Sun T; Zhang N; Cui N; Wang SH; Ding XX; Li N; Chen N; Yu ZB
J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):344-349. PubMed ID: 36473763
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
Meng JB; Hu MH; Lai ZZ; Ji CL; Xu XJ; Zhang G; Tian S
Med Sci Monit; 2016 May; 22():1486-96. PubMed ID: 27138236
[TBL] [Abstract][Full Text] [Related]
3. [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock].
Fang M; Dong S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):692-6. PubMed ID: 25315937
[TBL] [Abstract][Full Text] [Related]
4. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
Xu CX; Li L; Gong SJ; Yu YH; Yan J
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):423-428. PubMed ID: 29925127
[No Abstract] [Full Text] [Related]
5. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
Bhattacharjee S; Soni KD; Maitra S; Baidya DK
J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
Zangrillo A; Putzu A; Monaco F; Oriani A; Frau G; De Luca M; Di Tomasso N; Bignami E; Lomivorotov V; Likhvantsev V; Landoni G
J Crit Care; 2015 Oct; 30(5):908-13. PubMed ID: 26093802
[TBL] [Abstract][Full Text] [Related]
7. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.
Chang W; Xie JF; Xu JY; Yang Y
BMJ Open; 2018 Mar; 8(3):e019338. PubMed ID: 29602841
[TBL] [Abstract][Full Text] [Related]
8. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
[TBL] [Abstract][Full Text] [Related]
9. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study.
Kandasamy A; Simon HA; Murthy P; Annadurai M; Ali MM; Ramanathan G
Ann Card Anaesth; 2017; 20(2):200-206. PubMed ID: 28393781
[TBL] [Abstract][Full Text] [Related]
11. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
[TBL] [Abstract][Full Text] [Related]
12. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Huang L; Weil MH; Tang W; Sun S; Wang J
Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis.
Liu DH; Ning YL; Lei YY; Chen J; Liu YY; Lin XF; Yang ZQ; Xian SX; Chen WT
Sci Rep; 2021 Oct; 11(1):20333. PubMed ID: 34645892
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Duman D; Palit F; Simsek E; Bilgehan K; Sacide A
Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
[TBL] [Abstract][Full Text] [Related]
15. A Meta-Analysis of the Effects of Levosimendan on Cardiac Function and Outcomes in Patients with Sepsis.
Ma Z; Jin H; Liu F; Wang S; Huang P; Fang X
Altern Ther Health Med; 2023 Nov; 29(8):668-673. PubMed ID: 37678873
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
18. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of the Efficacy of Levosimendan in the Treatment of Severe Sepsis Complicated with Septic Cardiomyopathy.
Guan Q; Zhang C; Li B; Huang D; Li A; Qin J; Zhang X
Heart Surg Forum; 2023 Oct; 26(5):E609-E620. PubMed ID: 37920078
[TBL] [Abstract][Full Text] [Related]
20. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
Oldner A; Konrad D; Weitzberg E; Rudehill A; Rossi P; Wanecek M
Crit Care Med; 2001 Nov; 29(11):2185-93. PubMed ID: 11700420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
